HEPSERA Post Marketing Surveillance

• Status: Completed
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and/or efficacy of adefovir dipivoxil administered in Korean CHB patients according to the prescribing information

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Adefovir; Adefovir dipivoxil

Criteria

Inclusion Criteria:

• Patients administrated adefovir dipivoxil at the site

Exclusion Criteria:

• Patients administrated adefovir dipivoxil before center initiated date